HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

Virtual Incision closes $18mm Series B round

Executive Summary

Virtual Incision Corp. raised $18mm in its Series B financing co-led by first-time backer Sinopharm Capital and returning shareholder Bluestem Capital, which was joined by PrairieGold Venture Partners and undisclosed investors. The company will use the proceeds to submit the 510(k) premarket notification application for its next-generation miniaturized robotically assisted surgical device for less-invasive abdominal procedures.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies

UsernamePublicRestriction

Register